Market Recap Check: Emergent Biosolutions Inc (EBS)’s Negative Finish at 8.16, Up/Down -7.17

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The price of Emergent Biosolutions Inc (NYSE: EBS) closed at $8.16 in the last session, down -7.17% from day before closing price of $8.79. In other words, the price has decreased by -$7.17 from its previous closing price. On the day, 1.42 million shares were traded. EBS stock price reached its highest trading level at $8.86 during the session, while it also had its lowest trading level at $8.02.

Ratios:

We take a closer look at EBS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.20. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.32.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $16.

On March 07, 2024, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $5.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when DeGolyer Donald W sold 25,000 shares for $10.91 per share. The transaction valued at 272,750 led to the insider holds 111,100 shares of the business.

White Marvin L sold 14,287 shares of EBS for $171,015 on Nov 11 ’24. The Director now owns 54,092 shares after completing the transaction at $11.97 per share. On Nov 12 ’24, another insider, DeGolyer Donald W, who serves as the Director of the company, bought 25,000 shares for $11.77 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 442143072 and an Enterprise Value of 968242944. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.39 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at 0.86 whereas that against EBITDA is -201.717.

Stock Price History:

Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is -12.22%, while the 200-Day Moving Average is calculated to be 15.30%.

Shares Statistics:

According to the various share statistics, EBS traded on average about 1.58M shares per day over the past 3-months and 916250 shares per day over the past 10 days. A total of 54.10M shares are outstanding, with a floating share count of 52.05M. Insiders hold about 3.95% of the company’s shares, while institutions hold 58.58% stake in the company. Shares short for EBS as of 1732838400 were 6927172 with a Short Ratio of 4.40, compared to 1730332800 on 6948810. Therefore, it implies a Short% of Shares Outstanding of 6927172 and a Short% of Float of 15.529999.

Most Popular